Glide Pharma signs a biologics deal with a leading Japanese pharmaceutical company to conduct a feasibility study to trial the Glide SDI® technology with the said company’s novel therapeutic vaccine.
Glide Pharma signs a biologics deal with a leading Japanese pharmaceutical company to conduct a feasibility study to trial the Glide SDI® technology with the said company’s novel therapeutic vaccine.
